Advertisement

Altered Gene Expression Following Cardiopulmonary Bypass and Circulatory Arrest

  • Tatiana Zaitseva
  • Gregory Schears
  • Jin Shen
  • Jennifer Creed
  • David F. Wilson
  • Anna Pastuszko
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 530)

Abstract

This study investigated the effects of normothermic cardiopulmonary bypass (CPB) and circulatory arrest (DHCA) on expression of specific genes in neonatal piglet brain. CPB was performed through the chest at 100 ml/kg/min for 2 hrs at 37°C. In the second group of animals, CPB was begun as described above and then animals were cooled to a nasopharyngeal/brain temperature of 18°C. When the brain temperature reached I8°C, the CPB circuit was turned off. After 60 min of circulatory arrest (DHCA), CPB was resumed at 100 ml/kg/min, and the piglets were rewarmed to a temperature of 36°C. In both groups, the animals remain sedated, paralyzed, mechanically ventilated, and continuously monitored throughout a four hour study period after CPB. Oxygen pressure in the microvasculature of the cortex was measured by oxygen dependent quenching of phosphorescence. The aRNA technique was used to assess mRNA steady-state levels in the brain tissue.

Control oxygen pressure (pre-bypass) was 61 ± 5 Torr and during CPB this decreased to 32 ± 7 Torr on the beginning of bypass and to 36 ± 5 Ton at the end of bypass. During the recovery period, cortical oxygenation steadily decreased, reaching 29 ± 8 Ton at the end of the four hours period. Cortical oxygen decreased during DHCA to near zero and during rewarming and recovery increased to 35 ± 6 Torr.

Measurements of gene expression following CPB revealed significantly increased levels of mRNA for NMDAR1, DARPP-32, CamKII, GluR1, and D1AR. DHCA caused changes similar to those for CPB in levels of mRNA for NMDAR1, DARPP-32, CamKII and GluRl. In contrast, DHCA caused significantly increased levels of mRNA for GluR6 and GABRB1. There was no significant alteration in the level of D1AR following DHCA.

The results showed that DHCA caused much larger alterations in gene expression in the critical metabolic signaling pathways tested than did CPB.

Keywords

Cardiopulmonary bypass brain oxygen gene expression and newborn piglets 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    G Schears, J Shen, J Creed, T Zaitseva, DF Wilson, WJ Greeley, and A Pastuszko. Brain oxygenation during cardiopulmonary bypass and circulatory arrest. Adv. Exptl. Med. Biol. 510; 2003; 510: 325–330.CrossRefGoogle Scholar
  2. 2.
    WL Rumsey, JM Vanderkooi, and DF Wilson, Imaging of phosphorescence: a novel method for measuring oxygen distribution in perfused tissue. Science 1988; 241:1649–1651.PubMedCrossRefGoogle Scholar
  3. 3.
    SA Vinogradov, MA Femandez-Seara, BW Dugan, and DF Wilson, Frequency domain instrument for measuring phosphorescence lifetime distributions in heterogeneous samples. Rev. Sci. Inst. 72 (8); 2001: 3396–3406.CrossRefGoogle Scholar
  4. 4.
    J Eberwine, P Crino, and M Dichter, Single-cell mRNA amplification: implications for basic and clinical neuroscience. Neuroscientist 1995;1:200–211.CrossRefGoogle Scholar
  5. 5.
    J Phillips and JH Eberwine, Antisense RNA amplification: a linear amplification method for analyzing the mRNA population from single living cells. A Companion to Methods in Enzymol 1996;10:283–288.CrossRefGoogle Scholar
  6. 6.
    A Pastuszko, SN Lajevardi, J Chen, O Tammela, DF.Wilson, and M.Delivoria-Papadopoulos, Effects of graded levels of tissue oxygen pressure on dopamine metabolism in striatum of newbom piglets. J Neurochem 1993;60:161–166.PubMedCrossRefGoogle Scholar
  7. 7.
    A.Pastuszko, Metabolic response of dopaminergic system during hypoxia in newborn brain. Biochem Med Metab Biol 1994; 51:1–15.PubMedCrossRefGoogle Scholar
  8. 8.
    Ch-Ch Huang, NS Lajevardi, O.Tammela, A Pastuszko, M Delivoria-Papadopoulos, and DF.Wilson, Relationship of extracellular dopamine in striatum of newborn piglets to cortical oxygen pressure. Neurochem Res 1994; 19: 649–655.PubMedCrossRefGoogle Scholar
  9. 9.
    M Yonetani, Ch-Ch Huang, SN Lajevardi, A Pastuszko, M Delivoria-Papadopoulos, and DF Wilson, Effect of hemorrhagic hypotension on extracellular level of dopamine, cortical oxygen pressure and blood flow in brain of newborn piglets. Neuroscience Letters 1994;180:247–252.PubMedCrossRefGoogle Scholar
  10. 10.
    AA Fienberg, N Hiroi, PG Mermelstein, W-J Song, GL Snyder, A Nishi, A Cheramy, JP O’Callaghan, DB Miller, DG Cole, R Corbett, CN Haile, DC Cooper, SP Onn, AA Grace, CC Ouimet, FJ. White, SE Hyman, DJ Surmeier, J-A Girault, EJ Nestler, and P Greengard, DARPP-32: regulator of the efficacy of dopaminergic neurotransmission. Science 1998;281: 838–842.PubMedCrossRefGoogle Scholar
  11. 11.
    P Greengard, PB Allen, and AC Nairn, Beyond the dopamine receptor: the DARPP-32/protein phosphatase-1 cascade. [Review] Neuron 1999; 23:435–447.PubMedCrossRefGoogle Scholar
  12. 12.
    P Greengard, AC Naim, J-A Girault, CC Ouimet, GL Snyder, G Fisone, PB Allen, A Fienberg, and A Nishi, The DARPP-32/protein phosphatase-1 cascade: a model for signal integration. Brain Res Rev 1998; 26:274–284.PubMedCrossRefGoogle Scholar
  13. 13.
    P Svenningsson, M Lindskog, C Ledent, M Parmentier, P Greengard, BB Fredholm, and G Fisone, Regulation of the phosphorylation of the dopamine-and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine Dl, dopamine D2, and adenosine A2A receptors. PNAS, 2000;97:1856–1860.PubMedCrossRefGoogle Scholar
  14. 14.
    GL Snyder, PB Allen, AA Fienberg, CG Valle, RL Huganir, AC Nairn, and P Greengard, Regulation of phosphorylation of the GluR1 AMPA receptor in the neostriatum by dopamine and psychostimulants in vivo. J Neuroscience 2000; 20:4480–4488.Google Scholar
  15. 15.
    J. Flores-Hernandez, S. Hernandez, G.L. Snyder, Z. Yan, A.A. Fienberg, S.J. Moss, P. Greengard, and D.J. Surmeier, D(1) dopamine receptor activation reduces GABA(A) receptor currents in neostriatal neurons through a PKA/DARPP-32/PP1 signaling cascade. J Neurophysi 2000; 83: 2996–3004.Google Scholar
  16. 16.
    J.A. Bibb, G.L. Snyder, A. Nishi, Z Yan, L Meijer, A.A. Fienberg, L.H. Tsai, Y.T. Kwon, J.A. Girault, A.J. Czemik, R.L. Huganir, H.C. Hemmings, Jr., A.C. Naim, and P. Greengard, Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons. Nature 1999; 402 (6762):588–589, 669–671.Google Scholar
  17. 17.
    A. Nishi, G.L. Snyder, A.A. Fienberg, G. Fisone, A. Aperia, A.C. Naim, and P. Greengard, Requirement for DARPP-32 in mediating effect of dopamine D2 receptor activation. European Journal of Neuroscience 1999a;11: 2589–2592.CrossRefGoogle Scholar
  18. 18.
    A. Nishi, G.L. Snyder, A.C. Naim, and P. Greengard, Role of calcineurin and protein phosphatase 2A in the regulation of DARPP-32 dephosphorylation in neostriatal neurons. J Neurochem 1999b; 72:2015–2021.CrossRefGoogle Scholar
  19. 19.
    M. Lindskog, P. Svenningsson, B.B. Fredholm, P Greengard, and G. Fisone, Activation of dopamine D2 receptors decreases DARPP-32 phosphorylation in striatonigral and striatopallidal projection neurons via different mechanisms. Neuroscience 1999; 88:1005–1008.PubMedCrossRefGoogle Scholar
  20. 20.
    G.L. Snyder, A.A. Fienberg, R.L. Huganir, and P Greengard, A dopamine/D1 receptor/protein kinase A/dopamine-and cAMP-regulated phosphoprotein (Mr 32 kDa)/protein phosphatase-1 pathway regulates dephosphorylation of the NMDA receptor. Journal of Neuroscience 1998;18:10297–10303.PubMedGoogle Scholar
  21. 21.
    C.C. Ouimet, K.C. Langley-Gullion, and P. Greengard, Quantitative immunocytochemistry of DARPP-32-expressing neurons in the rat caudatoputamen. Brain Research 1998; 808:8–12.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2003

Authors and Affiliations

  • Tatiana Zaitseva
    • 2
  • Gregory Schears
    • 1
  • Jin Shen
    • 2
  • Jennifer Creed
    • 2
  • David F. Wilson
    • 2
  • Anna Pastuszko
    • 2
  1. 1.Children’s Hospital of PhiladelphiaPhiladelphiaUSA
  2. 2.Departments of Biochemistry & BiophysicsUniversity of Pennsylvania, School of Medicine and Anesthesiology & Critical CarePhiladelphiaUSA

Personalised recommendations